Neuroprotective effects of Meloxicam and Selegiline in scopolamine-induced cognitive impairment and oxidative stress

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Goverdhan, Puchchakayala ^a   Sravanthi, Akina ^a   Mamatha, Thati ^a  

^a Vaagdevi College of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ANTIOXIDANT; CATALASE; CYCLOOXYGENASE 2; MELOXICAM; SCOPOLAMINE; SELEGILINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; LEARNING DISORDER; LIPID PEROXIDATION; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84859760331     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/974013     Document Type: Article

References (31)

1. Jewart R. D., Green J., Cognitive, behavioral, and physiological changes in Alzheimer's disease patients as a function of incontinence medications American Journal of Geriatric Psychiatry 2005 13 4 324 328 (Pubitemid 41031080)
2. Selkoe D. J., Alzheimer's disease: a central role for amyloid Journal of Neuropathology and Experimental Neurology 1994 53 5 438 447 (Pubitemid 24276802)
3. Becker R., Giacobini E., Elble R., McIlhany M., Sherman K., Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration Acta Neurologica Scandinavica 1988 77 supplement 116 19 32
4. Rockwood K., Biomarkers to measure treatment effects in Alzheimer's disease: What should we look for? International Journal of Alzheimer's Disease 2011 2011 4
5. Bores G. M., Huger F. P., Petko W., Mutlib A. E., Camacho F., Rush D. K., Selk D. E., Wolf V., Kosley R. W., Davis L., Vargas H. M., Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine Journal of Pharmacology and Experimental Therapeutics 1996 277 2 728 738 (Pubitemid 27168982)
6. Silman I., Sussman J. L., Acetylcholinesterase: classical and non-classical functions and pharmacology Current Opinion in Pharmacology 2005 5 3 293 302 (Pubitemid 40674253)
7. Oh J. H., Choi B. J., Chang M. S., Park S. K., Nelumbo nucifera semen extract improves memory in rats with scopolamine-induced amnesia through the induction of choline acetyltransferase expression Neuroscience Letters 2009 461 1 41 44
8. Fan Y., Hu J., Li J., Yang Z., Xin X., Wang J., Ding J., Geng M., Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms Neuroscience Letters 2005 374 3 222 226 (Pubitemid 40128300)
9. Chen J., Long Y., Han M., Wang T., Chen Q., Wang R., Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice Pharmacology Biochemistry and Behavior 2008 90 3 441 446
10. Zandi P. P., Anthony J. C., Khachaturian A. S., Stone S. V., Gustafson D., Tschanz J. T., Norton M. C., Welsh-Bohmer K. A., Breitner J. C. S., Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the cache county study Archives of Neurology 2004 61 1 82 88 (Pubitemid 38067418)
11. Sano M., Ernesto C., Thomas R. G., Klauber M. R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C. W., Pfeiffer E., Schneider L. S., Thal L. J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease The New England Journal of Medicine 1997 336 17 1216 1222 (Pubitemid 27183651)
12. Wyss-Coray T., Mucke L., Inflammation in neurodegenerative diseasea double-edged sword Neuron 2002 35 3 419 432 (Pubitemid 34879943)
13. Smith W. L., DeWitt D. L., Garavito R. M., Cyclooxygenases: structural, cellular, and molecular biology Annual Review of Biochemistry 2000 69 145 182
14. Nivsarkar M., Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis Biochemical and Biophysical Research Communications 2000 270 3 714 716 (Pubitemid 30444770)
15. Kimura K., Mechanisms of active oxygen species reduction by non-steroidal anti-inflammatory drugs International Journal of Biochemistry and Cell Biology 1997 29 3 437 446 (Pubitemid 27230996)
16. Burak C. M. Y., Cimen O. B., Eskandari G., Sahin G., Erdogon C., Atik U., In vivo effects of meloxicam, celecoxib and ibuprofen on free radical mechanism in human erythrocytes Drug and Chemical Toxicology 2003 26 3 169 176 (Pubitemid 36951088)
17. Knoll J., The pharmacology of selegiline ((-)deprenyl). New aspects Acta Neurologica Scandinavica, Supplement 1989 126 83 91 (Pubitemid 20022081)
18. Kulkarni P. D., Ghaisas M. M., Chivate N. D., Sankpal P. S., Memory enhancing activity of Cissampelos pareira in mice International Journal of Pharmacy and Pharmaceutical Sciences 2011 3 2 206 211
19. Indumathy S., Kavimani S., Raman K. V., Role of angiotensin antagonists in memory enhancement International Journal of Pharma and Bio Sciences 2010 1 3
20. Vogel H. G., Schlkens B. A., Sandow J., Drug effects on learning and memory Drug Discovery and Evaluation: Pharmacological Assays 2002 2nd Berlin, Germany Springer 595 643
21. Morris R., Developments of a water-maze procedure for studying spatial learning in the rat Journal of Neuroscience Methods 1984 11 1 47 60 (Pubitemid 14088970)
22. Saraf M. K., Prabhakar S., Khanduja K. L., Anand A., Bacopa monniera attenuates scopolamine-induced impairment of spatial memory in mice Evidence-Based Complementary and Alternative Medicine 2011 2011 10
23. Yu Z. F., Cheng G. J., Hu B. R., Mechanism of colchicine impairment of learning and memory, and protective effect of CGP36742 in mice Brain Research 1997 750 1-2 53 58
24. Abhinav K., Jogender M., Madhusudana K., Naidu V. G. M., Gupta Y. K., Anti-amnesic activity of Vitex negundo in scopolamine induced amnesia in rats Pharmacology Pharmacy 2010 1 1 1 8
25. Kumar A., Samrita D., Prakash A., Neuroprotective effects of Centella asiatica against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress International Journal of Alzheimer's Disease 2009 2009 8
26. Kaur I. P., Geetha T., Screening methods for antioxidantsa review Mini-Reviews in Medicinal Chemistry 2006 6 3 305 312
27. Luck H., Bergmeyer H. U., Catalase in Methods of Enzymatic Analysis 1971 NewYork, NY, USA Academic Press 885 893
28. Stewart W. F., Kawas C., Corrada M., Metter E. J., Risk of Alzheimer's disease and duration of NSAID use Neurology 1997 48 3 626 632 (Pubitemid 27120096)
29. In 't Veld B. A., Ruitenberg A., Hofman A., Launer L. J., van Duijn C. M., Stijnen T., Breteler M. M. B., Stricker B. H. C., Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease The New England Journal of Medicine 2001 345 21 1515 1521 (Pubitemid 33144916)
30. El-Sherbiny D. A., Khalifa A. E., Attia A. S., Eldenshary E. E. S., Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine Pharmacology Biochemistry and Behavior 2003 76 3-4 525 533 (Pubitemid 37487909)
31. Jeong E. J., Lee K. Y., Kim S. H., Sung S. H., Kim Y. C., Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice European Journal of Pharmacology 2008 588 1 78 84